Hyliion (NYSE:HYLN) Upgraded to Hold by Northland Capmk

Northland Capmk upgraded shares of Hyliion (NYSE:HYLN) to a hold rating in a report published on Tuesday morning, Zacks.com reports. Northland Capmk also issued estimates for Hyliion’s Q3 2024 earnings at ($0.07) EPS, Q4 2024 earnings at ($0.07) EPS and FY2024 earnings at ($0.29) EPS.

Separately, Northland Securities upped their target price on Hyliion from $1.50 to $2.00 and gave the company a market perform rating in a research note on Tuesday, August 13th.

Hyliion Stock Down 1.2 %

NYSE:HYLN opened at $2.44 on Tuesday. Hyliion has a fifty-two week low of $0.52 and a fifty-two week high of $2.73. The firm’s fifty day simple moving average is $2.03 and its 200-day simple moving average is $1.75. The stock has a market cap of $424.65 million, a PE ratio of -4.00 and a beta of 1.90.

Hyliion (NYSE:HYLN) last announced its quarterly earnings results on Tuesday, August 6th. The company reported ($0.06) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.02. Equities analysts anticipate that Hyliion will post -0.29 earnings per share for the current year.

Insider Activity

In other Hyliion news, insider Govindaraj Ramasamy purchased 30,000 shares of Hyliion stock in a transaction on Wednesday, September 11th. The shares were bought at an average price of $1.92 per share, with a total value of $57,600.00. Following the purchase, the insider now directly owns 298,000 shares in the company, valued at $572,160. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 20.40% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in HYLN. AQR Capital Management LLC acquired a new position in Hyliion during the second quarter valued at approximately $40,000. The Manufacturers Life Insurance Company raised its position in Hyliion by 20.7% in the second quarter. The Manufacturers Life Insurance Company now owns 58,072 shares of the company’s stock valued at $94,000 after purchasing an additional 9,948 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of Hyliion by 9.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 104,086 shares of the company’s stock worth $184,000 after buying an additional 8,580 shares during the period. HITE Hedge Asset Management LLC acquired a new stake in shares of Hyliion in the second quarter valued at about $656,000. Finally, Bank of New York Mellon Corp raised its holdings in shares of Hyliion by 9.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 574,988 shares of the company’s stock valued at $931,000 after buying an additional 51,794 shares during the period. 22.81% of the stock is owned by hedge funds and other institutional investors.

Hyliion Company Profile